Product Image

Melatonin 10 mg Natural Cherry Flavor

Nature's Bounty
4.7
★ ★ ★ ★ ★
(3113 ratings)
Melatonin 10 mg
Product Image
Score71

Quick dissolution is convenient, but the 10 mg dose is unnecessarily high and short-lived.

How scoring works
Quantity:45 Tablet(s) • (45 servings)
Goals:
Sleep Support

Score 71

Quick dissolution is convenient, but the 10 mg dose is unnecessarily high and short-lived.

How scoring works
$9.79($0.21 per serving)
iHerb
$ 14.18
Vitacost
$ 14.18
Walmart
$ 11.35
Amazon
$ 9.79
Report prices

Analysis

The quick-dissolve tablet delivers 10 mg melatonin with natural cherry flavor. Its format may be useful for people who dislike swallowing pills.

The amount is far above a conservative starting range. Quick release favors onset but does not maintain support through the night.

Only 45 servings are included, and the high dose limits flexibility. It fits established high-dose users rather than people exploring melatonin for the first time.

Who is it for
  • Experienced adults using 10 mg
  • Users who prefer dissolving tablets
  • People focused on rapid sleep onset
Best for
  • Guided high-dose onset support
  • Pill-free nighttime use
  • Short-term established routines

Pros

  • Quick-dissolve format
  • One-tablet serving
  • Clear 10 mg amount
  • Cherry flavor

Cons

  • Very high dose
  • Only 45 servings
  • No sustained release
  • Flavor ingredients are not fully supplied

Warnings

  • Ten milligrams may cause morning grogginess, vivid dreams, or headache
  • Do not combine with alcohol or sedatives without guidance
  • Quick dissolve does not make middle-of-the-night redosing safe

Nutrient quality

64 Moderate impact

The standard delivery format offers no controlled overnight release. The high melatonin amount is unnecessarily aggressive for many users.

Ingredient transparency

83 Highest impact

All listed active ingredients have individual amounts and no proprietary blend hides them. Daily directions and the complete inactive-ingredient list are not supplied.

Customer satisfaction

69 High impact

The supplied average is favorable and the aggregate pool is substantial. No specific feedback is provided to assess recurring complaints or whether experience matches the intended use.

Value for money

65 High impact

Serving cost is comparatively high for the disclosed formula. The unnecessarily high amount weakens value for cautious routine use.

Report analysis

Goals

Sleep Support
Impact
High effect
A+ Goal FitC Strength of SupportD CoverageA- Formula Quality
Melatonin · 10 mg

Melatonin directly supports sleep timing and may help with difficulty falling asleep. The 10 mg amount is far above conservative physiological use and is clearly disclosed in a quick-dissolve tablet.

The high amount may increase vivid dreams or next-day grogginess without adding dependable benefit over lower doses. The focused design does not address stress, muscle tension, or other common barriers to sleep.

Study evidence
Melatonin Supportive 181 studies

Ingredients

IngredientAmount per serving
Melatonin
10 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free Women Vegetarian
Report overview
Melatonin · 10 mg OverallScore52
F Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyC Value

The quick-dissolve tablet supports rapid use and provides the full dose in one unit. Its high melatonin amount may increase next-day grogginess despite the convenient delivery. The price is moderate, but no sustained-release feature or independent purity certification is disclosed.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  2. Efficacy on sleep parameters and tolerability of melatonin in individuals with sleep or mental disorders: A systematic review and meta-analysis.
    Salanitro M; Wrigley T; Ghabra H; de Haan E; Hill CM; Solmi M; Cortese S · Neuroscience and biobehavioral reviews · 2022
    Meta-analysis1,998 participants34 studies pooledSleep Support forMelatonin
  3. Exogenous melatonin as a treatment for secondary sleep disorders: A systematic review and meta-analysis.
    Li T; Jiang S; Han M; Yang Z; Lv J; Deng C; Reiter RJ; Yang Y · Frontiers in neuroendocrinology · 2019
    Meta-analysis205 participants7 studies pooledSleep Support forMelatonin
  4. Efficacy of melatonin with behavioural sleep-wake scheduling for delayed sleep-wake phase disorder: A double-blind, randomised clinical trial.
    Sletten TL; Magee M; Murray JM; Gordon CJ; Lovato N; Kennaway DJ; Gwini SM; Bartlett DJ; Lockley SW; Lack LC; Grunstein RR; Rajaratnam SMW; Delayed Sleep on Melatonin (DelSoM) Study Group · PLoS medicine · 2019
    Randomized trial116 participantsSleep Support forMelatonin
  5. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  6. Effects of melatonin on postoperative sleep quality: a systematic review, meta-analysis, and trial sequential analysis.
    Tsukinaga A; Mihara T; Takeshima T; Tomita M; Goto T · Canadian journal of anaesthesia = Journal canadien d'anesthesie · 2023
    Meta-analysis516 participants8 studies pooledSleep Support forMelatonin
  7. Unintended consequences: college students' melatonin usage, sleep disturbance, and depressive symptoms.
    Peltz JS; Rogge R · Sleep and biological rhythms · 2025
    Cohort study331 participantsSleep Support forMelatonin
  8. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  9. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  10. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin